Medpace (MEDP) Competitors $501.22 -17.47 (-3.37%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$482.50 -18.72 (-3.73%) As of 10/10/2025 07:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MEDP vs. ICLR, EHC, ELV, HIMS, IQV, TCOM, RDDT, WCN, GRAB, and AERShould you be buying Medpace stock or one of its competitors? The main competitors of Medpace include Icon (ICLR), Encompass Health (EHC), Elevance Health (ELV), Hims & Hers Health (HIMS), IQVIA (IQV), Trip.com Group (TCOM), Reddit (RDDT), Waste Connections (WCN), Grab (GRAB), and Aercap (AER). Medpace vs. Its Competitors Icon Encompass Health Elevance Health Hims & Hers Health IQVIA Trip.com Group Reddit Waste Connections Grab Aercap Icon (NASDAQ:ICLR) and Medpace (NASDAQ:MEDP) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership and dividends. Which has more risk & volatility, ICLR or MEDP? Icon has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Comparatively, Medpace has a beta of 1.4, suggesting that its stock price is 40% more volatile than the S&P 500. Is ICLR or MEDP more profitable? Medpace has a net margin of 18.74% compared to Icon's net margin of 9.82%. Medpace's return on equity of 67.66% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Icon9.82% 10.95% 6.23% Medpace 18.74%67.66%21.86% Do institutionals & insiders believe in ICLR or MEDP? 95.6% of Icon shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 44.0% of Icon shares are held by insiders. Comparatively, 20.3% of Medpace shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has stronger valuation & earnings, ICLR or MEDP? Icon has higher revenue and earnings than Medpace. Icon is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIcon$8.28B1.79$791.47M$9.7218.88Medpace$2.11B6.68$404.39M$13.4537.27 Does the media prefer ICLR or MEDP? In the previous week, Medpace had 4 more articles in the media than Icon. MarketBeat recorded 19 mentions for Medpace and 15 mentions for Icon. Icon's average media sentiment score of 0.83 beat Medpace's score of 0.76 indicating that Icon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 8 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medpace 7 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate ICLR or MEDP? Icon currently has a consensus price target of $217.33, indicating a potential upside of 18.44%. Medpace has a consensus price target of $422.27, indicating a potential downside of 15.75%. Given Icon's stronger consensus rating and higher possible upside, equities analysts plainly believe Icon is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Icon 0 Sell rating(s) 9 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 2.65Medpace 3 Sell rating(s) 12 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryIcon beats Medpace on 9 of the 17 factors compared between the two stocks. Get Medpace News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MEDP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MEDP vs. The Competition Export to ExcelMetricMedpaceMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.08B$8.18B$6.01B$10.25BDividend YieldN/A2.16%5.67%4.76%P/E Ratio37.2774.6486.0326.55Price / Sales6.6833.45527.90191.78Price / Cash35.9221.7037.2660.57Price / Book18.876.7612.756.52Net Income$404.39M$247.60M$3.31B$276.43M7 Day Performance-5.87%-4.12%0.79%-0.88%1 Month Performance2.16%-2.79%6.67%3.48%1 Year Performance44.07%7.73%77.62%30.15% Medpace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEDPMedpace4.299 of 5 stars$501.22-3.4%$422.27-15.8%+44.1%$14.08B$2.11B37.275,900Trending NewsAnalyst ForecastAnalyst RevisionICLRIcon3.888 of 5 stars$163.44-0.2%$216.67+32.6%-38.1%$13.23B$8.28B16.8141,900Analyst ForecastAnalyst RevisionEHCEncompass Health4.8444 of 5 stars$125.83-0.7%$138.43+10.0%+27.2%$12.76B$5.37B24.6240,000Analyst ForecastELVElevance Health4.5276 of 5 stars$319.52+0.3%$411.06+28.6%-29.6%$71.74B$177.01B9.65104,200Trending NewsAnalyst ForecastAnalyst RevisionHIMSHims & Hers Health3.2834 of 5 stars$59.06+1.1%$38.92-34.1%+188.8%$13.20B$1.48B108.151,637Insider TradeIQVIQVIA4.885 of 5 stars$181.00+0.8%$229.64+26.9%-13.5%$30.53B$15.41B26.1988,000Trending NewsAnalyst ForecastAnalyst RevisionTCOMTrip.com Group4.5963 of 5 stars$76.14+0.3%$76.98+1.1%+7.8%$49.60B$7.30B23.0141,073Positive NewsAnalyst ForecastGap UpRDDTReddit2.8007 of 5 stars$241.98+0.8%$201.58-16.7%+171.4%$44.94B$1.30B218.282,233Trending NewsAnalyst ForecastInsider TradeWCNWaste Connections4.9248 of 5 stars$174.09+1.0%$213.00+22.3%-4.9%$44.24B$8.92B34.9723,854News CoverageAnalyst ForecastGRABGrab1.7371 of 5 stars$6.11flat$5.90-3.4%+60.5%$24.60B$2.80B152.7511,267Analyst ForecastAERAercap2.5814 of 5 stars$121.36-1.4%$122.57+1.0%+28.2%$23.00B$8.00B7.55740News CoverageAnalyst Forecast Related Companies and Tools Related Companies Icon Alternatives Encompass Health Alternatives Elevance Health Alternatives Hims & Hers Health Alternatives IQVIA Alternatives Trip.com Group Alternatives Reddit Alternatives Waste Connections Alternatives Grab Alternatives Aercap Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MEDP) was last updated on 10/12/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredGOLD ALERTGold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" E...Stansberry Research | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredBitcoin hits $125K… but the real story is hiding elsewhereA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medpace Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medpace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
